Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes

por Fei, Cheng-Ming, Guo, Juan, Zhao, You-Shan, Zhao, Si-Da, Zhen, Qing-Qing, Shi, Lei, Li, Xiao, Chang, Chun-Kang
Publicado 2018

Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome

por Xu, Feng, Liu, Li, Chang, Chun-Kang, He, Qi, Wu, Ling-Yun, Zhang, Zheng, Shi, Wen-Hui, Guo, Juan, Zhu, Yang, Zhao, You-Shan, Gu, Shu-Cheng, Fei, Cheng-Ming, Li, Xiao
Publicado 2016

Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome

por Xu, Feng, He, Qi, Li, Xiao, Chang, Chun-Kang, Wu, Ling-Yun, Zhang, Zheng, Liu, Li, Shi, Wen-Hui, Zhu, Yang, Zhao, You-Shan, Gu, Shu-Cheng, Fei, Cheng-Ming, Guo, Juan, Wu, Dong, Zhou, Liyu
Publicado 2014

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes

por Xu, Feng, Wu, Ling-Yun, Chang, Chun-Kang, He, Qi, Zhang, Zheng, Liu, Li, Shi, Wen-Hui, Guo, Juan, Zhu, Yang, Zhao, You-Shan, Gu, Shu-Cheng, Fei, Cheng-Ming, Wu, Dong, Zhou, Li-Yu, Su, Ji-Ying, Song, Lu-Xi, Xiao, Chao, Li, Xiao
Publicado 2015